{"disease":{"id":"infections-streptococcal","name":"infections streptococcal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00861380","title":"Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":41188,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00466947","title":"COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":23802,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00839254","title":"Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6181,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04841369","title":"Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3420,"lead_sponsor_name":"CanSino Biologics Inc.","has_results":false},{"nct_id":"NCT01545375","title":"Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1806,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01262872","title":"Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1320,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00370396","title":"Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02270944","title":"Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1053,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01616459","title":"Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":953,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01235949","title":"Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":850,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00344318","title":"Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":806,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00652951","title":"Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":780,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00547248","title":"Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":756,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00496015","title":"Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":750,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07017777","title":"A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"CanSino Biologics Inc.","has_results":false},{"nct_id":"NCT00345358","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01204658","title":"Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":576,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00624819","title":"Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":524,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00680914","title":"Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":503,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00829010","title":"Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":489,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00808444","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":466,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00950833","title":"Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":466,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01641133","title":"Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":457,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00911144","title":"Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00678301","title":"Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00814710","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01027845","title":"Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00307034","title":"Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00327665","title":"Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":335,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT02447432","title":"A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01153841","title":"Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01175083","title":"Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00390910","title":"Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01030822","title":"Booster and Catch-up Vaccination With Vaccine GSK1024850A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00985751","title":"Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":257,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00609492","title":"Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":245,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01119625","title":"Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":238,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04100772","title":"Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"CanSino Biologics Inc.","has_results":false},{"nct_id":"NCT00489554","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00985465","title":"Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":218,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02838407","title":"Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.","phase":"NA","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00792909","title":"Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00756067","title":"Evaluation of Pneumococcal Vaccine Formulations in Elderly","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00513409","title":"Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00707798","title":"Evaluation of Pneumococcal Vaccine Formulations in Young Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00307541","title":"Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01153893","title":"Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01485406","title":"Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00907777","title":"Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01746108","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}